FDA approves AJOVY for paediatric migraine prevention - PharmaTimes Teva’s CGRP therapy becomes first approved option for children and adolescent

#neurology #neurosciencetherapies #FDA #USA #AJOVY #fremanezumabvfrm #paediatricmigraine #paediatricmigraineprevention #Teva #CGRPtherapy #TevaPharmaceuticals #episodicmigraine #CGRPantagonist #paediatricepisodicmigraineprevention #Migraine #paediatricmigraine
pharmatimes.com/news/fda-app...